These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20826547)

  • 1. Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.
    Pratt-Hyatt M; Lin HL; Hollenberg PF
    Drug Metab Dispos; 2010 Dec; 38(12):2286-92. PubMed ID: 20826547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.
    Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
    Chem Res Toxicol; 2002 Dec; 15(12):1561-71. PubMed ID: 12482238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CYP2E1 mediates the formation of glycidamide from acrylamide.
    Settels E; Bernauer U; Palavinskas R; Klaffke HS; Gundert-Remy U; Appel KE
    Arch Toxicol; 2008 Oct; 82(10):717-27. PubMed ID: 18418580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of naturally occurring isothiocyanates on the activities of cytochrome P450 2E1 and the mutant P450 2E1 T303A.
    Moreno RL; Goosen T; Kent UM; Chung FL; Hollenberg PF
    Arch Biochem Biophys; 2001 Jul; 391(1):99-110. PubMed ID: 11414690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity.
    Viaggi C; Vaglini F; Pardini C; Sgadò P; Caramelli A; Corsini GU
    J Neural Transm Suppl; 2007; (72):159-63. PubMed ID: 17982890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between trifluoroacetic acid and hepatic protein trifluoroacetylation after disulfiram inhibition of halothane metabolism in rats.
    Spracklin DK; Emery ME; Thummel KE; Kharasch ED
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):765-70. PubMed ID: 12803597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel reversible inactivation of cytochrome P450 2E1 T303A by tert-butyl acetylene: the role of threonine 303 in proton delivery to the active site of cytochrome P450 2E1.
    Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):281-90. PubMed ID: 14988423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
    Ligocka D; Lison D; Haufroid V
    Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
    Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
    Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of disulfiram and its reduced metabolite, diethyl-dithiocarbamate on aldehyde dehydrogenase of human erythrocytes.
    Inoue K; Fukunaga M; Yamasawa K
    Life Sci; 1982 Feb; 30(5):419-24. PubMed ID: 6278237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.
    Lin HL; Zhang H; Noon KR; Hollenberg PF
    J Pharmacol Exp Ther; 2009 Nov; 331(2):392-403. PubMed ID: 19700628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF; Branch RA
    Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats.
    Brady JF; Xiao F; Wang MH; Li Y; Ning SM; Gapac JM; Yang CS
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):366-73. PubMed ID: 1850173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1.
    Sheets PL; Yost GS; Carlson GP
    J Biochem Mol Toxicol; 2004; 18(2):92-9. PubMed ID: 15122651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate.
    Moreno RL; Kent UM; Hodge K; Hollenberg PF
    Chem Res Toxicol; 1999 Jul; 12(7):582-7. PubMed ID: 10409397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretranslational and posttranslational regulation of rat hepatic CYPs 3A2 and 2E1 by disulfiram.
    Martini R; Ingelman-Sundberg M; Murray M
    Biochem Pharmacol; 1997 Dec; 54(12):1323-9. PubMed ID: 9393675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diethylthiocarbamic acid methyl ester. A potent inhibitor of aldehyde dehydrogenase found in rats treated with disulfiram or diethyldithiocarbamic acid methyl ester.
    Johansson B; Petersen EN; Arnold E
    Biochem Pharmacol; 1989 Apr; 38(7):1053-9. PubMed ID: 2539814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory toxicity of diethyldithiocarbamate (DDTC) and disulfiram and the protective effect of DDTC against the olfactory toxicity of dichlobenil.
    Deamer NJ; Genter MB
    Chem Biol Interact; 1995 Apr; 95(3):215-26. PubMed ID: 7728893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans.
    Emery MG; Jubert C; Thummel KE; Kharasch ED
    J Pharmacol Exp Ther; 1999 Oct; 291(1):213-9. PubMed ID: 10490907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.